 | • レポートコード：MRC2102QY10125 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、142ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界の臓器移植免疫抑制剤市場について種類別（タクロリムス、ミコフェノール酸モフェチル、シクロスポリン、その他）、用途別（肝移植、腎臓移植、心臓移植、その他の臓器移植）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・臓器移植免疫抑制剤市場の概要 ・世界の主要地域別臓器移植免疫抑制剤市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の臓器移植免疫抑制剤市場規模2015-2026：種類別（タクロリムス、ミコフェノール酸モフェチル、シクロスポリン、その他） ・世界の臓器移植免疫抑制剤市場規模2015-2026：用途別（肝移植、腎臓移植、心臓移植、その他の臓器移植） ・臓器移植免疫抑制剤の米国市場規模2015-2020 ・臓器移植免疫抑制剤のヨーロッパ市場規模2015-2020 ・臓器移植免疫抑制剤の中国市場規模2015-2020 ・臓器移植免疫抑制剤の日本市場規模2015-2020 ・臓器移植免疫抑制剤の東南アジア市場規模2015-2020 ・臓器移植免疫抑制剤のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・臓器移植免疫抑制剤の製造コスト分析 ・販売チャネル、流通業者、顧客 ・臓器移植免疫抑制剤の市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Organ Transplant Immunosuppressant Market
The global Organ Transplant Immunosuppressant market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Organ Transplant Immunosuppressant Scope and Market Size
The global Organ Transplant Immunosuppressant market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Organ Transplant Immunosuppressant market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Organ Transplant Immunosuppressant market is segmented into
Tacrolimus
Mycophenolate Mofetil
Cyclosporin
Others
Segment by Application, the Organ Transplant Immunosuppressant market is segmented into
Liver Transplant
Kidney Transplant
Heart Transplant
Other Organ Transplant
The Organ Transplant Immunosuppressant market is analysed and market size information is provided by regions (countries). Segment by Application, the Organ Transplant Immunosuppressant market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Organ Transplant Immunosuppressant Market Share Analysis
Organ Transplant Immunosuppressant market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Organ Transplant Immunosuppressant business, the date to enter into the Organ Transplant Immunosuppressant market, Organ Transplant Immunosuppressant product introduction, recent developments, etc.
The major vendors covered:
Roche
Astellas Pharma Inc.
Huadong Pharmaceutical
Novartis
Catalent Pharma
Cinkate Corporation
Cilag
Genzyme
Changzhou Pharm
North China Pharmaceutical Group Corporation
SL PHARM
Livzon Pharmaceutical Group Inc.,
Sirio Pharma Co., Ltd
1 Organ Transplant Immunosuppressant Market Overview
1.1 Organ Transplant Immunosuppressant Product Scope
1.2 Organ Transplant Immunosuppressant Segment by Type
1.2.1 Global Organ Transplant Immunosuppressant Sales by Type (2020-2026)
1.2.2 Tacrolimus
1.2.3 Mycophenolate Mofetil
1.2.4 Cyclosporin
1.2.5 Others
1.3 Organ Transplant Immunosuppressant Segment by Application
1.3.1 Global Organ Transplant Immunosuppressant Sales Comparison by Application (2020-2026)
1.3.2 Liver Transplant
1.3.3 Kidney Transplant
1.3.4 Heart Transplant
1.3.5 Other Organ Transplant
1.4 Organ Transplant Immunosuppressant Market Estimates and Forecasts (2015-2026)
1.4.1 Global Organ Transplant Immunosuppressant Sales Growth Rate (2015-2026)
1.4.2 Global Organ Transplant Immunosuppressant Revenue and Growth Rate (2015-2026)
1.4.3 Global Organ Transplant Immunosuppressant Price Trends (2015-2026)
2 Organ Transplant Immunosuppressant Estimate and Forecast by Region
2.1 Global Organ Transplant Immunosuppressant Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Organ Transplant Immunosuppressant Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Organ Transplant Immunosuppressant Sales Market Share by Region (2015-2020)
2.2.2 Global Organ Transplant Immunosuppressant Revenue Market Share by Region (2015-2020)
2.3 Global Organ Transplant Immunosuppressant Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Organ Transplant Immunosuppressant Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Organ Transplant Immunosuppressant Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Organ Transplant Immunosuppressant Estimates and Projections (2015-2026)
2.4.2 Europe Organ Transplant Immunosuppressant Estimates and Projections (2015-2026)
2.4.3 China Organ Transplant Immunosuppressant Estimates and Projections (2015-2026)
2.4.4 Japan Organ Transplant Immunosuppressant Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Organ Transplant Immunosuppressant Estimates and Projections (2015-2026)
2.4.6 India Organ Transplant Immunosuppressant Estimates and Projections (2015-2026)
3 Global Organ Transplant Immunosuppressant Competition Landscape by Players
3.1 Global Top Organ Transplant Immunosuppressant Players by Sales (2015-2020)
3.2 Global Top Organ Transplant Immunosuppressant Players by Revenue (2015-2020)
3.3 Global Organ Transplant Immunosuppressant Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Organ Transplant Immunosuppressant as of 2019)
3.4 Global Organ Transplant Immunosuppressant Average Price by Company (2015-2020)
3.5 Manufacturers Organ Transplant Immunosuppressant Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Organ Transplant Immunosuppressant Players (Opinion Leaders)
4 Global Organ Transplant Immunosuppressant Market Size by Type
4.1 Global Organ Transplant Immunosuppressant Historic Market Review by Type (2015-2020)
4.1.1 Global Organ Transplant Immunosuppressant Sales Market Share by Type (2015-2020)
4.1.2 Global Organ Transplant Immunosuppressant Revenue Market Share by Type (2015-2020)
4.1.3 Global Organ Transplant Immunosuppressant Price by Type (2015-2020)
4.2 Global Organ Transplant Immunosuppressant Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Organ Transplant Immunosuppressant Sales Forecast by Type (2021-2026)
4.2.2 Global Organ Transplant Immunosuppressant Revenue Forecast by Type (2021-2026)
4.2.3 Global Organ Transplant Immunosuppressant Price Forecast by Type (2021-2026)
5 Global Organ Transplant Immunosuppressant Market Size by Application
5.1 Global Organ Transplant Immunosuppressant Historic Market Review by Application (2015-2020)
5.1.1 Global Organ Transplant Immunosuppressant Sales Market Share by Application (2015-2020)
5.1.2 Global Organ Transplant Immunosuppressant Revenue Market Share by Application (2015-2020)
5.1.3 Global Organ Transplant Immunosuppressant Price by Application (2015-2020)
5.2 Global Organ Transplant Immunosuppressant Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Organ Transplant Immunosuppressant Sales Forecast by Application (2021-2026)
5.2.2 Global Organ Transplant Immunosuppressant Revenue Forecast by Application (2021-2026)
5.2.3 Global Organ Transplant Immunosuppressant Price Forecast by Application (2021-2026)
6 United States Organ Transplant Immunosuppressant Market Facts & Figures
6.1 United States Organ Transplant Immunosuppressant Sales Market Share by Company (2015-2020)
6.2 United States Organ Transplant Immunosuppressant Sales Market Share by Type (2015-2020)
6.3 United States Organ Transplant Immunosuppressant Sales Market Share by Application (2015-2020)
7 Europe Organ Transplant Immunosuppressant Market Facts & Figures
7.1 Europe Organ Transplant Immunosuppressant Sales Market Share by Company (2015-2020)
7.2 Europe Organ Transplant Immunosuppressant Sales Market Share by Type (2015-2020)
7.3 Europe Organ Transplant Immunosuppressant Sales Market Share by Application (2015-2020)
8 China Organ Transplant Immunosuppressant Market Facts & Figures
8.1 China Organ Transplant Immunosuppressant Sales Market Share by Company (2015-2020)
8.2 China Organ Transplant Immunosuppressant Sales Market Share by Type (2015-2020)
8.3 China Organ Transplant Immunosuppressant Sales Market Share by Application (2015-2020)
9 Japan Organ Transplant Immunosuppressant Market Facts & Figures
9.1 Japan Organ Transplant Immunosuppressant Sales Market Share by Company (3015-3030)
9.2 Japan Organ Transplant Immunosuppressant Sales Market Share by Type (2015-2020)
9.3 Japan Organ Transplant Immunosuppressant Sales Market Share by Application (2015-2020)
10 Southeast Asia Organ Transplant Immunosuppressant Market Facts & Figures
10.1 Southeast Asia Organ Transplant Immunosuppressant Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Organ Transplant Immunosuppressant Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Organ Transplant Immunosuppressant Sales Market Share by Application (2015-2020)
11 India Organ Transplant Immunosuppressant Market Facts & Figures
11.1 India Organ Transplant Immunosuppressant Sales Market Share by Company (2015-2020)
11.2 India Organ Transplant Immunosuppressant Sales Market Share by Type (2015-2020)
11.3 India Organ Transplant Immunosuppressant Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Organ Transplant Immunosuppressant Business
12.1 Roche
12.1.1 Roche Corporation Information
12.1.2 Roche Business Overview
12.1.3 Roche Organ Transplant Immunosuppressant Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Roche Organ Transplant Immunosuppressant Products Offered
12.1.5 Roche Recent Development
12.2 Astellas Pharma Inc.
12.2.1 Astellas Pharma Inc. Corporation Information
12.2.2 Astellas Pharma Inc. Business Overview
12.2.3 Astellas Pharma Inc. Organ Transplant Immunosuppressant Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Astellas Pharma Inc. Organ Transplant Immunosuppressant Products Offered
12.2.5 Astellas Pharma Inc. Recent Development
12.3 Huadong Pharmaceutical
12.3.1 Huadong Pharmaceutical Corporation Information
12.3.2 Huadong Pharmaceutical Business Overview
12.3.3 Huadong Pharmaceutical Organ Transplant Immunosuppressant Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Huadong Pharmaceutical Organ Transplant Immunosuppressant Products Offered
12.3.5 Huadong Pharmaceutical Recent Development
12.4 Novartis
12.4.1 Novartis Corporation Information
12.4.2 Novartis Business Overview
12.4.3 Novartis Organ Transplant Immunosuppressant Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Novartis Organ Transplant Immunosuppressant Products Offered
12.4.5 Novartis Recent Development
12.5 Catalent Pharma
12.5.1 Catalent Pharma Corporation Information
12.5.2 Catalent Pharma Business Overview
12.5.3 Catalent Pharma Organ Transplant Immunosuppressant Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Catalent Pharma Organ Transplant Immunosuppressant Products Offered
12.5.5 Catalent Pharma Recent Development
12.6 Cinkate Corporation
12.6.1 Cinkate Corporation Corporation Information
12.6.2 Cinkate Corporation Business Overview
12.6.3 Cinkate Corporation Organ Transplant Immunosuppressant Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Cinkate Corporation Organ Transplant Immunosuppressant Products Offered
12.6.5 Cinkate Corporation Recent Development
12.7 Cilag
12.7.1 Cilag Corporation Information
12.7.2 Cilag Business Overview
12.7.3 Cilag Organ Transplant Immunosuppressant Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Cilag Organ Transplant Immunosuppressant Products Offered
12.7.5 Cilag Recent Development
12.8 Genzyme
12.8.1 Genzyme Corporation Information
12.8.2 Genzyme Business Overview
12.8.3 Genzyme Organ Transplant Immunosuppressant Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Genzyme Organ Transplant Immunosuppressant Products Offered
12.8.5 Genzyme Recent Development
12.9 Changzhou Pharm
12.9.1 Changzhou Pharm Corporation Information
12.9.2 Changzhou Pharm Business Overview
12.9.3 Changzhou Pharm Organ Transplant Immunosuppressant Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Changzhou Pharm Organ Transplant Immunosuppressant Products Offered
12.9.5 Changzhou Pharm Recent Development
12.10 North China Pharmaceutical Group Corporation
12.10.1 North China Pharmaceutical Group Corporation Corporation Information
12.10.2 North China Pharmaceutical Group Corporation Business Overview
12.10.3 North China Pharmaceutical Group Corporation Organ Transplant Immunosuppressant Sales, Revenue and Gross Margin (2015-2020)
12.10.4 North China Pharmaceutical Group Corporation Organ Transplant Immunosuppressant Products Offered
12.10.5 North China Pharmaceutical Group Corporation Recent Development
12.11 SL PHARM
12.11.1 SL PHARM Corporation Information
12.11.2 SL PHARM Business Overview
12.11.3 SL PHARM Organ Transplant Immunosuppressant Sales, Revenue and Gross Margin (2015-2020)
12.11.4 SL PHARM Organ Transplant Immunosuppressant Products Offered
12.11.5 SL PHARM Recent Development
12.12 Livzon Pharmaceutical Group Inc.,
12.12.1 Livzon Pharmaceutical Group Inc., Corporation Information
12.12.2 Livzon Pharmaceutical Group Inc., Business Overview
12.12.3 Livzon Pharmaceutical Group Inc., Organ Transplant Immunosuppressant Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Livzon Pharmaceutical Group Inc., Organ Transplant Immunosuppressant Products Offered
12.12.5 Livzon Pharmaceutical Group Inc., Recent Development
12.13 Sirio Pharma Co., Ltd
12.13.1 Sirio Pharma Co., Ltd Corporation Information
12.13.2 Sirio Pharma Co., Ltd Business Overview
12.13.3 Sirio Pharma Co., Ltd Organ Transplant Immunosuppressant Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Sirio Pharma Co., Ltd Organ Transplant Immunosuppressant Products Offered
12.13.5 Sirio Pharma Co., Ltd Recent Development
13 Organ Transplant Immunosuppressant Manufacturing Cost Analysis
13.1 Organ Transplant Immunosuppressant Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Organ Transplant Immunosuppressant
13.4 Organ Transplant Immunosuppressant Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Organ Transplant Immunosuppressant Distributors List
14.3 Organ Transplant Immunosuppressant Customers
15 Market Dynamics
15.1 Organ Transplant Immunosuppressant Market Trends
15.2 Organ Transplant Immunosuppressant Opportunities and Drivers
15.3 Organ Transplant Immunosuppressant Market Challenges
15.4 Organ Transplant Immunosuppressant Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Organ Transplant Immunosuppressant Sales (K Units) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Organ Transplant Immunosuppressant Sales (K Units) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Organ Transplant Immunosuppressant Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Organ Transplant Immunosuppressant Sales (K Units) by Region (2015-2020)
Table 5. Global Organ Transplant Immunosuppressant Sales Market Share by Region (2015-2020)
Table 6. Global Organ Transplant Immunosuppressant Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Organ Transplant Immunosuppressant Revenue Share by Region (2015-2020)
Table 8. Global Organ Transplant Immunosuppressant Sales (K Units) Forecast by Region (2021-2026)
Table 9. Global Organ Transplant Immunosuppressant Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Organ Transplant Immunosuppressant Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Organ Transplant Immunosuppressant Revenue Share Forecast by Region (2021-2026)
Table 12. Global Organ Transplant Immunosuppressant (K Units) of Key Companies (2015-2020)
Table 13. Global Organ Transplant Immunosuppressant Sales Share by Company (2015-2020)
Table 14. Global Organ Transplant Immunosuppressant Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Organ Transplant Immunosuppressant Revenue Share by Company (2015-2020)
Table 16. Global Organ Transplant Immunosuppressant by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Organ Transplant Immunosuppressant as of 2019)
Table 17. Global Organ Transplant Immunosuppressant Average Price (US$/Unit) of Key Company (2015-2020)
Table 18. Manufacturers Organ Transplant Immunosuppressant Manufacturing Sites and Area Served
Table 19. Manufacturers Organ Transplant Immunosuppressant Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Organ Transplant Immunosuppressant Players
Table 22. Global Organ Transplant Immunosuppressant Sales (K Units) by Type (2015-2020)
Table 23. Global Organ Transplant Immunosuppressant Sales Share by Type (2015-2020)
Table 24. Global Organ Transplant Immunosuppressant Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Organ Transplant Immunosuppressant Price (K Units) by Type (2015-2020)
Table 26. Global Organ Transplant Immunosuppressant Sales Share by Type (2021-2026)
Table 27. Global Organ Transplant Immunosuppressant Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Organ Transplant Immunosuppressant Revenue Share by Type (2021-2026)
Table 29. Global Organ Transplant Immunosuppressant Price (K Units) by Type (2021-2026)
Table 30. Global Organ Transplant Immunosuppressant Sales (K Units) by Application (2015-2020)
Table 31. Global Organ Transplant Immunosuppressant Sales Share by Application (2015-2020)
Table 32. Global Organ Transplant Immunosuppressant Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Organ Transplant Immunosuppressant Price (K Units) by Application (2015-2020)
Table 34. Global Organ Transplant Immunosuppressant Sales (K Units) by Application (2021-2026)
Table 35. Global Organ Transplant Immunosuppressant Sales Share by Application (2021-2026)
Table 36. Global Organ Transplant Immunosuppressant Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Organ Transplant Immunosuppressant Revenue Share by Application (2021-2026)
Table 38. Global Organ Transplant Immunosuppressant Price (K Units) by Application (2021-2026)
Table 39. United States Organ Transplant Immunosuppressant Sales (K Units) by Company (2015-2020)
Table 40. United States Organ Transplant Immunosuppressant Sales Market Share by Company (2015-2020)
Table 41. United States Organ Transplant Immunosuppressant Sales (K Units) by Type (2015-2020)
Table 42. United States Organ Transplant Immunosuppressant Sales Market Share by Type (2015-2020)
Table 43. United States Organ Transplant Immunosuppressant Sales (K Units) by Application (2015-2020)
Table 44. United States Organ Transplant Immunosuppressant Sales Market Share by Application (2015-2020)
Table 45. Europe Organ Transplant Immunosuppressant Sales (K Units) by Company (2015-2020)
Table 46. Europe Organ Transplant Immunosuppressant Sales Market Share by Company (2015-2020)
Table 47. Europe Organ Transplant Immunosuppressant Sales (K Units) by Type (2015-2020)
Table 48. Europe Organ Transplant Immunosuppressant Sales Market Share by Type (2015-2020)
Table 49. Europe Organ Transplant Immunosuppressant Sales (K Units) by Application (2015-2020)
Table 50. Europe Organ Transplant Immunosuppressant Sales Market Share by Type (2015-2020)
Table 51. China Organ Transplant Immunosuppressant Sales (K Units) by Company (2015-2020)
Table 52. China Organ Transplant Immunosuppressant Sales Market Share by Company (2015-2020)
Table 53. China Organ Transplant Immunosuppressant Sales (K Units) by Type (2015-2020)
Table 54. China Organ Transplant Immunosuppressant Sales Market Share by Type (2015-2020)
Table 55. China Organ Transplant Immunosuppressant Sales (K Units) by Application (2015-2020)
Table 56. China Organ Transplant Immunosuppressant Sales Market Share by Application (2015-2020)
Table 57. Japan Organ Transplant Immunosuppressant Sales (K Units) by Company (2015-2020)
Table 58. Japan Organ Transplant Immunosuppressant Sales Market Share by Company (2015-2020)
Table 59. Japan Organ Transplant Immunosuppressant Sales (K Units) by Type (2015-2020)
Table 60. Japan Organ Transplant Immunosuppressant Sales Market Share by Type (2015-2020)
Table 61. Japan Organ Transplant Immunosuppressant Sales (K Units) by Application (2015-2020)
Table 62. Japan Organ Transplant Immunosuppressant Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Organ Transplant Immunosuppressant Sales (K Units) by Company (2015-2020)
Table 64. Southeast Asia Organ Transplant Immunosuppressant Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Organ Transplant Immunosuppressant Sales (K Units) by Type (2015-2020)
Table 66. Southeast Asia Organ Transplant Immunosuppressant Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Organ Transplant Immunosuppressant Sales (K Units) by Type (2015-2020)
Table 68. Southeast Asia Organ Transplant Immunosuppressant Sales Market Share by Application (2015-2020)
Table 69. India Organ Transplant Immunosuppressant Sales (K Units) by Company (2015-2020)
Table 70. India Organ Transplant Immunosuppressant Sales Market Share by Company (2015-2020)
Table 71. India Organ Transplant Immunosuppressant Sales (K Units) by Type (2015-2020)
Table 72. India Organ Transplant Immunosuppressant Sales Market Share by Type (2015-2020)
Table 73. India Organ Transplant Immunosuppressant Sales (K Units) by Application (2015-2020)
Table 74. India Organ Transplant Immunosuppressant Sales Market Share by Application (2015-2020)
Table 75. Roche Corporation Information
Table 76. Roche Description and Business Overview
Table 77. Roche Organ Transplant Immunosuppressant Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2015-2020)
Table 78. Roche Organ Transplant Immunosuppressant Product
Table 79. Roche Recent Development
Table 80. Astellas Pharma Inc. Corporation Information
Table 81. Astellas Pharma Inc. Description and Business Overview
Table 82. Astellas Pharma Inc. Organ Transplant Immunosuppressant Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2015-2020)
Table 83. Astellas Pharma Inc. Organ Transplant Immunosuppressant Product
Table 84. Astellas Pharma Inc. Recent Development
Table 85. Huadong Pharmaceutical Corporation Information
Table 86. Huadong Pharmaceutical Description and Business Overview
Table 87. Huadong Pharmaceutical Organ Transplant Immunosuppressant Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2015-2020)
Table 88. Huadong Pharmaceutical Organ Transplant Immunosuppressant Product
Table 89. Huadong Pharmaceutical Recent Development
Table 90. Novartis Corporation Information
Table 91. Novartis Description and Business Overview
Table 92. Novartis Organ Transplant Immunosuppressant Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2015-2020)
Table 93. Novartis Organ Transplant Immunosuppressant Product
Table 94. Novartis Recent Development
Table 95. Catalent Pharma Corporation Information
Table 96. Catalent Pharma Description and Business Overview
Table 97. Catalent Pharma Organ Transplant Immunosuppressant Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2015-2020)
Table 98. Catalent Pharma Organ Transplant Immunosuppressant Product
Table 99. Catalent Pharma Recent Development
Table 100. Cinkate Corporation Corporation Information
Table 101. Cinkate Corporation Description and Business Overview
Table 102. Cinkate Corporation Organ Transplant Immunosuppressant Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2015-2020)
Table 103. Cinkate Corporation Organ Transplant Immunosuppressant Product
Table 104. Cinkate Corporation Recent Development
Table 105. Cilag Corporation Information
Table 106. Cilag Description and Business Overview
Table 107. Cilag Organ Transplant Immunosuppressant Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2015-2020)
Table 108. Cilag Organ Transplant Immunosuppressant Product
Table 109. Cilag Recent Development
Table 110. Genzyme Corporation Information
Table 111. Genzyme Organ Transplant Immunosuppressant Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2015-2020)
Table 112. Genzyme Description and Business Overview
Table 113. Genzyme Organ Transplant Immunosuppressant Product
Table 114. Genzyme Recent Development
Table 115. Changzhou Pharm Corporation Information
Table 116. Changzhou Pharm Organ Transplant Immunosuppressant Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2015-2020)
Table 117. Changzhou Pharm Description and Business Overview
Table 118. Changzhou Pharm Organ Transplant Immunosuppressant Product
Table 119. Changzhou Pharm Recent Development
Table 120. North China Pharmaceutical Group Corporation Corporation Information
Table 121. North China Pharmaceutical Group Corporation Description and Business Overview
Table 122. North China Pharmaceutical Group Corporation Organ Transplant Immunosuppressant Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2015-2020)
Table 123. North China Pharmaceutical Group Corporation Organ Transplant Immunosuppressant Product
Table 124. North China Pharmaceutical Group Corporation Recent Development
Table 125. SL PHARM Corporation Information
Table 126. SL PHARM Description and Business Overview
Table 127. SL PHARM Organ Transplant Immunosuppressant Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2015-2020)
Table 128. SL PHARM Organ Transplant Immunosuppressant Product
Table 129. SL PHARM Recent Development
Table 130. Livzon Pharmaceutical Group Inc., Corporation Information
Table 131. Livzon Pharmaceutical Group Inc., Description and Business Overview
Table 132. Livzon Pharmaceutical Group Inc., Organ Transplant Immunosuppressant Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2015-2020)
Table 133. Livzon Pharmaceutical Group Inc., Organ Transplant Immunosuppressant Product
Table 134. Livzon Pharmaceutical Group Inc., Recent Development
Table 135. Sirio Pharma Co., Ltd Corporation Information
Table 136. Sirio Pharma Co., Ltd Description and Business Overview
Table 137. Sirio Pharma Co., Ltd Organ Transplant Immunosuppressant Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2015-2020)
Table 138. Sirio Pharma Co., Ltd Organ Transplant Immunosuppressant Product
Table 139. Sirio Pharma Co., Ltd Recent Development
Table 140. Production Base and Market Concentration Rate of Raw Material
Table 141. Key Suppliers of Raw Materials
Table 142. Organ Transplant Immunosuppressant Distributors List
Table 143. Organ Transplant Immunosuppressant Customers List
Table 144. Organ Transplant Immunosuppressant Market Key Trends
Table 145. Organ Transplant Immunosuppressant Key Opportunities and Drivers
Table 146. Organ Transplant Immunosuppressant Market Challenges
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Organ Transplant Immunosuppressant Product Picture
Figure 2. Global Organ Transplant Immunosuppressant Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Organ Transplant Immunosuppressant Market Share by Application in 2020 & 2026
Figure 6. Liver Transplant Examples
Figure 7. Kidney Transplant Examples
Figure 8. Heart Transplant Examples
Figure 9. Other Organ Transplant Examples
Figure 10. Global Organ Transplant Immunosuppressant Sales (K Units) Growth Rate (2015-2026)
Figure 11. Global Organ Transplant Immunosuppressant Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global Organ Transplant Immunosuppressant Price Trends Growth Rate (2015-2026) (US$/Unit)
Figure 13. Global Organ Transplant Immunosuppressant Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global Organ Transplant Immunosuppressant Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States Organ Transplant Immunosuppressant Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States Organ Transplant Immunosuppressant Sales (K Units) Growth Rate (2015-2026)
Figure 17. Europe Organ Transplant Immunosuppressant Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe Organ Transplant Immunosuppressant Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China Organ Transplant Immunosuppressant Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China Organ Transplant Immunosuppressant Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan Organ Transplant Immunosuppressant Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan Organ Transplant Immunosuppressant Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Organ Transplant Immunosuppressant Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Organ Transplant Immunosuppressant Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India Organ Transplant Immunosuppressant Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India Organ Transplant Immunosuppressant Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest Organ Transplant Immunosuppressant Players Market Share by Revenue in Organ Transplant Immunosuppressant 2015 & 2019
Figure 28. Organ Transplant Immunosuppressant Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Organ Transplant Immunosuppressant Revenue Share by Type (2015-2020)
Figure 30. Global Organ Transplant Immunosuppressant Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global Organ Transplant Immunosuppressant Revenue Share by Application (2015-2020)
Figure 32. Global Organ Transplant Immunosuppressant Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States Organ Transplant Immunosuppressant Sales Market Share by Type in 2019
Figure 34. United States Organ Transplant Immunosuppressant Sales Market Share by Type in 2019
Figure 35. Europe Organ Transplant Immunosuppressant Sales Market Share by Company in 2019
Figure 36. Europe Organ Transplant Immunosuppressant Sales Market Share by Type in 2019
Figure 37. Europe Organ Transplant Immunosuppressant Sales Market Share by Application in 2019
Figure 38. China Organ Transplant Immunosuppressant Sales Market Share by Company in 2019
Figure 39. China Organ Transplant Immunosuppressant Sales Market Share by Type in 2019
Figure 40. China Organ Transplant Immunosuppressant Sales Market Share by Application in 2019
Figure 41. Japan Organ Transplant Immunosuppressant Sales Market Share by Company in 2019
Figure 42. Japan Organ Transplant Immunosuppressant Sales Market Share by Type in 2019
Figure 43. Japan Organ Transplant Immunosuppressant Sales Market Share by Application in 2019
Figure 44. Southeast Asia Organ Transplant Immunosuppressant Sales Market Share by Company in 2019
Figure 45. Southeast Asia Organ Transplant Immunosuppressant Sales Market Share by Type in 2019
Figure 46. Southeast Asia Organ Transplant Immunosuppressant Sales Market Share by Application in 2019
Figure 47. India Organ Transplant Immunosuppressant Sales Market Share by Company in 2019
Figure 48. India Organ Transplant Immunosuppressant Sales Market Share by Type in 2019
Figure 49. India Organ Transplant Immunosuppressant Sales Market Share by Application in 2019
Figure 50. Key Raw Materials Price Trend
Figure 51. Manufacturing Cost Structure of Organ Transplant Immunosuppressant
Figure 52. Manufacturing Process Analysis of Organ Transplant Immunosuppressant
Figure 53. Organ Transplant Immunosuppressant Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Porter's Five Forces Analysis
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
生体機能チップの世界市場レポート2020 An organ-on-a-chip (OOC) is a multi-channel 3-D microfluidic cell culture chip that simulates the activities, mechanics and physiological response of entire organs and organ systems, a type of artificial organ. It constitutes the subject matter of significant biomedical engineering research, more pr…- 骨盤臓器脱修復装置の世界市場レポート2020 Pelvic organ prolapse, or POP, is the dropping of the pelvic organs caused by the loss of normal support of the vagina. There are 5 types of POP; organs that can prolapse are the bladder (cystocele), intestines (enterocele), rectum (rectocele), uterus (uterine), and vagina (vaginal vault). The techn…
- 外部骨固定プレートの世界市場レポート2020 Market Analysis and Insights: Global External Bone Fixation Plate Market The global External Bone Fixation Plate market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global External Bone Fixation Plate Scope and Market Size The glo…
- 内部骨固定プレートの世界市場レポート2020 Market Analysis and Insights: Global Internal Bone Fixation Plate Market The global Internal Bone Fixation Plate market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Internal Bone Fixation Plate Scope and Market Size The glo…
- 心肺自動輸血システムの世界市場レポート2020 Cardiopulmonary Autotransfusion System is a sophisticated device with an exceptionally effective design that provides autologous blood during surgical procedures. Autotransfusion is a process wherein a person receives their own blood for a transfusion, instead of banked allogenic (separate-donor) bl…